NCT02683538View on ClinicalTrials.gov

Radiofrequency Ablation Using Octopus Electrodes for Treatment of Focal Liver Malignancies

PHASE2CompletedINTERVENTIONAL
Enrollment

196

Participants

Timeline

Start Date

November 30, 2011

Primary Completion Date

July 31, 2013

Study Completion Date

July 31, 2014

Conditions
Hepatocellular CarcinomaMetastasisCholangiocarcinoma
Interventions
DEVICE

Separable cluster electrode (Octopus®)

Patients undergo RFA under ultrasound guidance, and separable cluster electrodes are used for RFA in monopolar switching mode, using multiple overlapping technique to create larger ablative zones.

Trial Locations (1)

Unknown

Seoul National University Hospital, Seoul

All Listed Sponsors
lead

Seoul National University Hospital

OTHER

NCT02683538 - Radiofrequency Ablation Using Octopus Electrodes for Treatment of Focal Liver Malignancies | Biotech Hunter | Biotech Hunter